Rhinital (Tablets) Instructions for Use
Marketing Authorization Holder
Alpen Pharma, GmbH (Germany)
Manufactured By
Deutsche Homoeopathie-Union DHU-Arzneimittel GmbH & Co. KG (Germany)
Or
Dr. Willmar Schwabe GmbH & Co. KG (Germany)
Labeled By
Dr. WILLMAR SCHWABE, GmbH & Co.KG (Germany)
Quality Control Release
DEUTSCHE HOMOEOPATHIE-UNION DHU-ARZNEIMITTEL, GmbH & Co.KG (Germany)
ATC Code
V30 (Not assigned)
Dosage Form
| Rhinital | Homeopathic sublingual tablets: 100 pcs. |
Dosage Form, Packaging, and Composition
Homeopathic sublingual tablets white or almost white in color, flat-cylindrical in shape, with a bevel.
| 1 tab. | |
| Luffa operculata D4 | 25 mg |
| Galphimia glauca D3 | 25 mg |
| Cardiospermum halicacabum (Cardiospermum) D3 | 25 mg |
Excipients: lactose monohydrate – 165 mg, wheat starch – 8.5 mg, magnesium stearate – 1.5 mg.
20 pcs. – blisters (5) – cartons.
Clinical-Pharmacological Group
Homeopathic preparation with anti-allergic action
Pharmacotherapeutic Group
Homeopathic agent
Pharmacological Action
A homeopathic preparation with anti-allergic action. It has anti-edematous, anti-pruritic, and anti-inflammatory effects. Reduces increased secretion in the nasal sinuses.
Pharmacokinetics
The pharmacokinetics of Rhinital have not been studied.
Indications
- Allergic rhinitis caused by plant pollen;
- Perennial allergic rhinitis (as part of combination therapy).
ICD codes
| ICD-10 code | Indication |
| J30.1 | Allergic rhinitis due to pollen |
| J30.3 | Other allergic rhinitis (perennial allergic rhinitis) |
| ICD-11 code | Indication |
| CA08.00 | Allergic rhinitis due to pollen |
| CA08.03 | Other allergic rhinitis |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
For acute course of the disease, adults and children over 12 years are prescribed 1 tablet every hour (no more than 12 times/day) until improvement occurs. Subsequently, 1-2 tablets are prescribed 3 times/day.
Children from 6 to 12 years are prescribed 1 tablet every hour (no more than 8 times/day) until improvement occurs. Subsequently, 1-2 tablets are prescribed 2 times/day.
For allergic rhinitis caused by plant pollen, for preventive purposes, adults and children over 12 years are prescribed 1 tablet 3 times/day; children from 6 to 12 years are prescribed 1 tablet 2 times/day. Treatment should be started 6 weeks before the appearance of the pollen causing the allergy.
The tablets should be taken 30 minutes before or 30 minutes after a meal, slowly dissolving them in the mouth.
Long-term use of the drug is possible.
Adverse Reactions
Possible allergic reactions.
Contraindications
- Hypersensitivity to the components of the drug.
Use in Pregnancy and Lactation
If it is necessary to use Rhinital during pregnancy and lactation, the expected benefit for the mother and the potential risk to the fetus should be weighed.
Pediatric Use
For acute course of the disease, children over 12 years are prescribed 1 tablet every hour (no more than 12 times/day) until improvement occurs. Subsequently, 1-2 tablets are prescribed 3 times/day.
Children from 6 to 12 years are prescribed 1 tablet every hour (no more than 8 times/day) until improvement occurs. Subsequently, 1-2 tablets are prescribed 2 times/day.
For allergic rhinitis caused by plant pollen, for preventive purposes, children over 12 years are prescribed 1 tablet 3 times/day; children from 6 to 12 years are prescribed 1 tablet 2 times/day. Treatment should be started 6 weeks before the appearance of the pollen causing the allergy.
Special Precautions
When using Rhinital, a temporary worsening of the condition is possible. In this case, the patient should stop taking the drug and consult a doctor.
When using Rhinital, the use of other medications is allowed.
Overdose
To date, no cases of overdose with Rhinital have been reported.
Drug Interactions
Drug interactions of Rhinital have not been described.
Storage Conditions
The drug should be stored out of the reach of children at a temperature between 15°C (59°F) and 25°C (77°F).
Shelf Life
Shelf life – 5 years.
Dispensing Status
The drug is available without a prescription.
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer